- Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
-
Shimizu H, Fujii T, Hibiya S, Motobayashi M, Suzuki K, Takenaka K, Saito E, Nagahori M, Ohtsuka K, Watanabe M
- KMID: 2512107
- Intest Res.
- 2021 Jan;19(1):115-118.
- doi: 10.5217/ir.2020.00030
-
- CITED
-
- Close
- SHARE
-
- Close
- Population-Based Incidence Rates of Subarachnoid Hemorrhage in Japan: The Shiga Stroke and Heart Attack Registry
-
Shitara S, Tanaka-Mizuno S, Takashima N, Fujii T, Arima H, Kita Y, Tsuji A, Kitamura A, Urushitani M, Miura K, Nozaki K, on Behalf of the Shiga Stroke and Heart Attack Registry Group
- KMID: 2530532
- J Stroke.
- 2022 May;24(2):292-295.
- doi: 10.5853/jos.2022.00087
-
- CITED
-
- Close
- SHARE
-
- Close
- Tacrolimus for the Treatment of Ulcerative Colitis
-
Matsuoka K, Saito E, Fujii T, Takenaka K, Kimura M, Nagahori M, Ohtsuka K, Watanabe M
- KMID: 2174466
- Intest Res.
- 2015 Jul;13(3):219-226.
- doi: 10.5217/ir.2015.13.3.219
Tacrolimus is a calcineurin inhibitor used for the treatment of corticosteroid-refractory ulcerative colitis (UC). Two randomized controlled trials and a number of retrospective studies have assessed the therapeutic effect of... -
- CITED
-
- Close
- SHARE
-
- Close
- Magnetic resonance enterography for the evaluation of the deep small intestine in Crohn's disease
-
Ohtsuka K, Takenaka K, Kitazume Y, Fujii T, Matsuoka K, Kimura M, Nagaishi T, Watanabe M
- KMID: 2425284
- Intest Res.
- 2016 Apr;14(2):120-126.
- doi: 10.5217/ir.2016.14.2.120
For the control of Crohn's disease (CD) a thorough assessment of the small intestine is essential; several modalities may be utilized, with cross-sectional imaging being important. Magnetic resonance (MR) enterography,... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
-
Shimizu H, Aonuma Y, Hibiya S, Kawamoto A, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Okamoto R
- KMID: 2558196
- Intest Res.
- 2024 Jul;22(3):369-377.
- doi: 10.5217/ir.2023.00194
Background/Aims: The efficacy and safety of tofacitinib for the treatment of refractory ulcerative colitis (UC) has been demonstrated in clinical trials. Although, a series of reports with real-world evidence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn’s disease activity confirmed by balloon-assisted enteroscopy
-
Kawamoto A, Takenaka K, Hibiya S, Kitazume Y, Shimizu H, Fujii T, Saito E, Ohtsuka K, Okamoto R
- KMID: 2551279
- Intest Res.
- 2024 Jan;22(1):65-74.
- doi: 10.5217/ir.2023.00092
Background/Aims: Endoscopic activity confirmed by enteroscopy is associated with poor clinical outcome in Crohn’s disease (CD). We investigated which of the existing biomarkers best reflects endoscopic activity in CD patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix
-
Murakami I, Fujii T, Kameyama K, Iwata T, Saito M, Kubushiro , Aoki D
- KMID: 2245173
- J Gynecol Oncol.
- 2012 Jul;23(3):153-158.
- doi: 10.3802/jgo.2012.23.3.153
OBJECTIVE: The aim of this study was to investigate the risk and recurrence of early invasive adenocarcinoma of the cervix, and to determine whether non-radical methods of management could be... -
- CITED
-
- Close
- SHARE
-
- Close
- p16INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping
-
Nishio S, Fujii T, Nishio H, Kameyama K, Saito M, Iwata T, Kubushiro , Aoki D
- KMID: 2288527
- J Gynecol Oncol.
- 2013 Jul;24(3):215-221.
- doi: 10.3802/jgo.2013.24.3.215
OBJECTIVE: In cervical intraepithelial neoplasia (CIN), p16INK4a immunohistochemistry has been reported to be a useful diagnostic biomarker. However, limited information is available about the association between the p16INK4a immunohistochemistry and... -
- CITED
-
- Close
- SHARE
-
- Close
- Smooth Muscle Cells Transplantation is better than Heart Cells Transplantation for Improvement of Heart Function in Dilated Cardiomyopathy
-
Yoo KJ, Li RK, Weisel RD, Mickle DA, Tomita S, Ohno N, Fujii T
- KMID: 1105097
- Yonsei Med J.
- 2002 Jun;43(3):296-303.
- doi: 10.3349/ymj.2002.43.3.296
Muscle cell transplantation may delay or prevent cardiac dilation in dilated cardiomyopathy. The present study was designed to compare the effects of the heart function of smooth muscle cell (SMCs)... -
- CITED
-
- Close
- SHARE
-
- Close
- Progressive Change in Joint Degeneration in Patients with Knee or Hip Osteoarthritis Treated with Fentanyl in a Randomized Trial
-
Fujii T, Takana K, Orita S, Inoue G, Ochiai N, Kuniyoshi , Aoki Y, Ishikawa T, Miyagi M, Kamoda H, Suzuki M, Sakuma Y, Kubota G, Oikawa Y, Inage K, Sainoh T, Sato J, Yamauchi K, Toyone T, Nakamura J, Kishida S, Takahashi , Ohtori S
- KMID: 1799506
- Yonsei Med J.
- 2014 Sep;55(5):1379-1385.
- doi: 10.3349/ymj.2014.55.5.1379
PURPOSE: Opioids improve pain from knee and hip osteoarthritis (OA) and decrease the functional impairment of patients. However, there is a possibility that opioids induce analgesia and suppress the physiological... -
- CITED
-
- Close
- SHARE
-
- Close
- Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
-
Hayashi T, Saitoh S, Fukuzawa K, Tsuji Y, Takahashi , Kawamura Y, Akuta N, Kobayashi , Ikeda K, Fujii T, Miyati T, Kumada H
- KMID: 2389356
- Gut Liver.
- 2017 Sep;11(5):674-683.
- doi: 10.5009/gnl16440
BACKGROUND/AIMS: Noninvasive liver fibrosis evaluation was performed in patients with nonalcoholic fatty liver disease (NAFLD). We used a quantitative method based on the hepatic volume acquired from gadoxetate disodium-enhanced (Gd-EOB-DTPA-enhanced)... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Survival after Stroke in 1.4 Million Japanese Population: Shiga Stroke and Heart Attack Registry
-
Takashima N, Arima H, Kita Y, Fujii T, Tanaka-Mizuno S, Shitara S, Kitamura A, Sugimoto Y, Urushitani M, Miura K, Nozaki K
- KMID: 2508037
- J Stroke.
- 2020 Sep;22(3):336-344.
- doi: 10.5853/jos.2020.00325
Background and Purpose Although numerous measures for stroke exist, stroke remains one of the leading causes of death in Japan. In this study, we aimed to determine the long-term survival... -
- CITED
-
- Close
- SHARE
-
- Close
- Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
-
Yamada R, Fujii T, Hattori K, Hori H, Matsumura R, Kurashimo T, Ishihara N, Yoshida S, Sumiyoshi T, Kunugi H
- KMID: 2542937
- Clin Psychopharmacol Neurosci.
- 2023 May;21(2):296-303.
- doi: 10.9758/cpn.2023.21.2.296
Objective: This study aimed to determine if the discrepancy between depression severity rated by clinicians and that reported by patients depends on key behavioral/psychological features in patients with mood disorders. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease
-
Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi , Oshita M, Tanaka H, Ozeki K, Takahashi , Kitamoto H, Kani K, Nanjo S, Sugaya T, Sakakibara Y, Inokuchi T, Kakimoto K, Yamada A, Yasuhara H, Yokoyama Y, Yoshino T, Matsui A, Nakamura M, Tomizawa T, Sakemi R, Kamata N, Hibi T
- KMID: 2434163
- Intest Res.
- 2018 Oct;16(4):609-618.
- doi: 10.5217/ir.2018.00044
BACKGROUND/AIMS: The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
